Logo image of STAR7.MI

STAR7 S.P.A. (STAR7.MI) Stock Fundamental Analysis

BIT:STAR7 - Euronext Milan - IT0005466195 - Common Stock - Currency: EUR

6.05  -0.25 (-3.97%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to STAR7. STAR7 was compared to 43 industry peers in the Commercial Services & Supplies industry. STAR7 has an average financial health and profitability rating. STAR7 is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

In the past year STAR7 was profitable.
Each year in the past 5 years STAR7 has been profitable.
STAR7 had a positive operating cash flow in 4 of the past 5 years.
STAR7.MI Yearly Net Income VS EBIT VS OCF VS FCFSTAR7.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 5M

1.2 Ratios

STAR7 has a Return On Assets of 1.79%. This is comparable to the rest of the industry: STAR7 outperforms 51.16% of its industry peers.
STAR7's Return On Equity of 6.76% is in line compared to the rest of the industry. STAR7 outperforms 51.16% of its industry peers.
STAR7 has a Return On Invested Capital of 6.94%. This is in the better half of the industry: STAR7 outperforms 74.42% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for STAR7 is below the industry average of 7.30%.
The last Return On Invested Capital (6.94%) for STAR7 is above the 3 year average (5.17%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 1.79%
ROE 6.76%
ROIC 6.94%
ROA(3y)2.24%
ROA(5y)3.03%
ROE(3y)8.64%
ROE(5y)12.9%
ROIC(3y)5.17%
ROIC(5y)7.39%
STAR7.MI Yearly ROA, ROE, ROICSTAR7.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 5 10 15 20

1.3 Margins

STAR7 has a Profit Margin (1.74%) which is in line with its industry peers.
STAR7's Profit Margin has declined in the last couple of years.
With a decent Operating Margin value of 6.81%, STAR7 is doing good in the industry, outperforming 69.77% of the companies in the same industry.
STAR7's Operating Margin has declined in the last couple of years.
The Gross Margin of STAR7 (59.19%) is better than 65.12% of its industry peers.
STAR7's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 6.81%
PM (TTM) 1.74%
GM 59.19%
OM growth 3Y1.64%
OM growth 5Y-7.03%
PM growth 3Y-20.35%
PM growth 5Y-17.44%
GM growth 3Y5.6%
GM growth 5Y5.72%
STAR7.MI Yearly Profit, Operating, Gross MarginsSTAR7.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 10 20 30 40 50

More info and screens

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so STAR7 is still creating some value.
The number of shares outstanding for STAR7 remains at a similar level compared to 1 year ago.
STAR7 has about the same amout of shares outstanding than it did 5 years ago.
STAR7 has a better debt/assets ratio than last year.
STAR7.MI Yearly Shares OutstandingSTAR7.MI Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M
STAR7.MI Yearly Total Debt VS Total AssetsSTAR7.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

2.2 Solvency

STAR7 has an Altman-Z score of 2.17. This is not the best score and indicates that STAR7 is in the grey zone with still only limited risk for bankruptcy at the moment.
STAR7 has a better Altman-Z score (2.17) than 69.77% of its industry peers.
STAR7 has a Debt/Equity ratio of 1.07. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.07, STAR7 is in line with its industry, outperforming 41.86% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.07
Debt/FCF N/A
Altman-Z 2.17
ROIC/WACC1.16
WACC5.98%
STAR7.MI Yearly LT Debt VS Equity VS FCFSTAR7.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 10M 20M 30M 40M

2.3 Liquidity

A Current Ratio of 1.69 indicates that STAR7 should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.69, STAR7 is in the better half of the industry, outperforming 79.07% of the companies in the same industry.
STAR7 has a Quick Ratio of 1.63. This is a normal value and indicates that STAR7 is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.63, STAR7 belongs to the top of the industry, outperforming 83.72% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.69
Quick Ratio 1.63
STAR7.MI Yearly Current Assets VS Current LiabilitesSTAR7.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M

More info and screens

3

3. Growth

3.1 Past

STAR7 shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -22.38%.
Measured over the past years, STAR7 shows a decrease in Earnings Per Share. The EPS has been decreasing by -1.37% on average per year.
Looking at the last year, STAR7 shows a very strong growth in Revenue. The Revenue has grown by 20.59%.
STAR7 shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 19.46% yearly.
EPS 1Y (TTM)-22.38%
EPS 3Y6.68%
EPS 5Y-1.37%
EPS Q2Q%21.26%
Revenue 1Y (TTM)20.59%
Revenue growth 3Y33.93%
Revenue growth 5Y19.46%
Sales Q2Q%18.69%

3.2 Future

The Earnings Per Share is expected to decrease by -3.03% on average over the next years.
Based on estimates for the next years, STAR7 will show a small growth in Revenue. The Revenue will grow by 7.42% on average per year.
EPS Next Y-40.99%
EPS Next 2Y-14.88%
EPS Next 3Y-2.75%
EPS Next 5Y-3.03%
Revenue Next Year14.12%
Revenue Next 2Y9.23%
Revenue Next 3Y8.05%
Revenue Next 5Y7.42%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
STAR7.MI Yearly Revenue VS EstimatesSTAR7.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M
STAR7.MI Yearly EPS VS EstimatesSTAR7.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 27.50 indicates a quite expensive valuation of STAR7.
STAR7's Price/Earnings is on the same level as the industry average.
STAR7 is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.75, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 8.45 indicates a reasonable valuation of STAR7.
Based on the Price/Forward Earnings ratio, STAR7 is valued cheaper than 88.37% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 20.49, STAR7 is valued rather cheaply.
Industry RankSector Rank
PE 27.5
Fwd PE 8.45
STAR7.MI Price Earnings VS Forward Price EarningsSTAR7.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of STAR7 indicates a somewhat cheap valuation: STAR7 is cheaper than 79.07% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 5.29
STAR7.MI Per share dataSTAR7.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

A cheap valuation may be justified as STAR7's earnings are expected to decrease with -2.75% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-14.88%
EPS Next 3Y-2.75%

More info and screens

0

5. Dividend

5.1 Amount

STAR7 does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

STAR7 S.P.A.

BIT:STAR7 (4/16/2025, 7:00:00 PM)

6.05

-0.25 (-3.97%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners11.66%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap54.45M
Analysts86
Price Target11.93 (97.19%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.18%
PT rev (3m)2.18%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-5.43%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.26%
Valuation
Industry RankSector Rank
PE 27.5
Fwd PE 8.45
P/S 0.48
P/FCF N/A
P/OCF N/A
P/B 1.86
P/tB N/A
EV/EBITDA 5.29
EPS(TTM)0.22
EY3.64%
EPS(NY)0.72
Fwd EY11.84%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS12.66
BVpS3.25
TBVpS-0.76
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.79%
ROE 6.76%
ROCE 10.74%
ROIC 6.94%
ROICexc 9.12%
ROICexgc 26.62%
OM 6.81%
PM (TTM) 1.74%
GM 59.19%
FCFM N/A
ROA(3y)2.24%
ROA(5y)3.03%
ROE(3y)8.64%
ROE(5y)12.9%
ROIC(3y)5.17%
ROIC(5y)7.39%
ROICexc(3y)6.64%
ROICexc(5y)9.34%
ROICexgc(3y)21.81%
ROICexgc(5y)22.14%
ROCE(3y)8%
ROCE(5y)11.44%
ROICexcg growth 3Y14.78%
ROICexcg growth 5Y-13.61%
ROICexc growth 3Y-2.29%
ROICexc growth 5Y-22.99%
OM growth 3Y1.64%
OM growth 5Y-7.03%
PM growth 3Y-20.35%
PM growth 5Y-17.44%
GM growth 3Y5.6%
GM growth 5Y5.72%
F-ScoreN/A
Asset Turnover1.03
Health
Industry RankSector Rank
Debt/Equity 1.07
Debt/FCF N/A
Debt/EBITDA 1.96
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.69
Quick Ratio 1.63
Altman-Z 2.17
F-ScoreN/A
WACC5.98%
ROIC/WACC1.16
Cap/Depr(3y)105.75%
Cap/Depr(5y)154.23%
Cap/Sales(3y)8.21%
Cap/Sales(5y)8.33%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-22.38%
EPS 3Y6.68%
EPS 5Y-1.37%
EPS Q2Q%21.26%
EPS Next Y-40.99%
EPS Next 2Y-14.88%
EPS Next 3Y-2.75%
EPS Next 5Y-3.03%
Revenue 1Y (TTM)20.59%
Revenue growth 3Y33.93%
Revenue growth 5Y19.46%
Sales Q2Q%18.69%
Revenue Next Year14.12%
Revenue Next 2Y9.23%
Revenue Next 3Y8.05%
Revenue Next 5Y7.42%
EBIT growth 1Y7.36%
EBIT growth 3Y36.12%
EBIT growth 5Y11.06%
EBIT Next Year49.58%
EBIT Next 3Y21.04%
EBIT Next 5Y17.91%
FCF growth 1Y-131.66%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y129.09%
OCF growth 3Y0.94%
OCF growth 5Y4.35%